DC Vaccine for Patients With Ductal Carcinoma In Situ
Clinical trial NCT02061332 · COMPLETED
Trial details
- NCT number
- NCT02061332
- Sponsor
- Abramson Cancer Center at Penn Medicine
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-07-01
- Primary completion
- 2014-08-08
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.